InvestorsHub Logo
Followers 3
Posts 931
Boards Moderated 0
Alias Born 03/30/2021

Re: None

Thursday, 04/25/2024 5:17:39 PM

Thursday, April 25, 2024 5:17:39 PM

Post# of 5268
TPOC Parkinson Disease test. Tear-based Point-of-Care test. This article is a month old but great summary about the new test developed by AXIM scientists.

https://www.darkdaily.com/?p=46757


Not investment advice.

Hashtags related to our company and partners.

Merchandising partner:
#VerséaOphthalmics
#VerséaHealth
#TPOC Tear based Point-of-Care
#DryEye #Diagnostics #Quantitative
#Lactoferrin #TotalIgE
#TPOCTITAN #TPOCTITANS
#Biovance #Biovance3L

Manufacturing Partner:
#AuerPrecision ISO Certified
#ISO9001 #ISO13485

#AXIMBIOTECH
#AXIMEYE #DryEye
#Parkinsons #TPOC #Diagnostics
#Lactoferrin #510K
510(k) Number K934473
#TotalIgE #510K
510(k) Number. K991316






Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News